357 related articles for article (PubMed ID: 1710525)
1. Identification of N-iminoethyl-L-ornithine as an irreversible inhibitor of nitric oxide synthase in phagocytic cells.
McCall TB; Feelisch M; Palmer RM; Moncada S
Br J Pharmacol; 1991 Jan; 102(1):234-8. PubMed ID: 1710525
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of inhibitors of nitric oxide synthase in immune complex-induced vasculitis.
Mulligan MS; Moncada S; Ward PA
Br J Pharmacol; 1992 Dec; 107(4):1159-62. PubMed ID: 1281719
[TBL] [Abstract][Full Text] [Related]
3. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo.
Rees DD; Palmer RM; Schulz R; Hodson HF; Moncada S
Br J Pharmacol; 1990 Nov; 101(3):746-52. PubMed ID: 1706208
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the L-arginine:nitric oxide pathway in human platelets.
Radomski MW; Palmer RM; Moncada S
Br J Pharmacol; 1990 Oct; 101(2):325-8. PubMed ID: 1701676
[TBL] [Abstract][Full Text] [Related]
5. Selective targeting of nitric oxide synthase inhibitors to system y+ in activated macrophages.
Baydoun AR; Mann GE
Biochem Biophys Res Commun; 1994 Apr; 200(2):726-31. PubMed ID: 7513994
[TBL] [Abstract][Full Text] [Related]
6. Role of nitric oxide synthesis in the regulation of coronary vascular tone in the isolated perfused rabbit heart.
Smith RE; Palmer RM; Bucknall CA; Moncada S
Cardiovasc Res; 1992 May; 26(5):508-12. PubMed ID: 1446321
[TBL] [Abstract][Full Text] [Related]
7. Role of nitric oxide synthase isozymes in endotoxin-induced uveitis.
Mandai M; Mittag TW; Kogishi J; Iwaki M; Hangai M; Yoshimura N
Invest Ophthalmol Vis Sci; 1996 Apr; 37(5):826-32. PubMed ID: 8603867
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide synthase inhibitors decrease human polymorphonuclear leukocyte luminol-dependent chemiluminescence.
Catz SD; Carreras MC; Poderoso JJ
Free Radic Biol Med; 1995 Dec; 19(6):741-8. PubMed ID: 8582646
[TBL] [Abstract][Full Text] [Related]
9. Kinetic characteristics of nitric oxide synthase from rat brain.
Knowles RG; Palacios M; Palmer RM; Moncada S
Biochem J; 1990 Jul; 269(1):207-10. PubMed ID: 1695842
[TBL] [Abstract][Full Text] [Related]
10. N-nitro-L-arginine and N-monomethyl-L-arginine exhibit a different pattern of inactivation toward the three nitric oxide synthases.
Reif DW; McCreedy SA
Arch Biochem Biophys; 1995 Jun; 320(1):170-6. PubMed ID: 7540822
[TBL] [Abstract][Full Text] [Related]
11. Determination of brain nitric oxide synthase inhibition in vivo: ex vivo assays of nitric oxide synthase can give incorrect results.
Salter M; Duffy C; Hazelwood R
Neuropharmacology; 1995 Mar; 34(3):327-34. PubMed ID: 7543191
[TBL] [Abstract][Full Text] [Related]
12. Characterization of endothelial cell amino acid transport systems involved in the actions of nitric oxide synthase inhibitors.
Schmidt K; Klatt P; Mayer B
Mol Pharmacol; 1993 Sep; 44(3):615-21. PubMed ID: 7690451
[TBL] [Abstract][Full Text] [Related]
13. Identification of inhibitors of nitric oxide synthase that do not interact with the endothelial cell L-arginine transporter.
Bogle RG; Moncada S; Pearson JD; Mann GE
Br J Pharmacol; 1992 Apr; 105(4):768-70. PubMed ID: 1380372
[TBL] [Abstract][Full Text] [Related]
14. Microbial killing by human neutrophil cytokineplasts: similar suppressive effects of reversible and irreversible inhibitors of nitric oxide synthase.
Malawista SE; Montgomery RR; Van Blaricom G
J Leukoc Biol; 1996 Dec; 60(6):753-7. PubMed ID: 8975878
[TBL] [Abstract][Full Text] [Related]
15. Impairment of osteoblast growth by nitric oxide synthase inhibitors: an effect independent of nitric oxide and arginine transport inhibition.
Riancho JA; Zarrabeitia MT; Salas E; González-Macías J
Methods Find Exp Clin Pharmacol; 1996 Dec; 18(10):663-7. PubMed ID: 9121222
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide inhibits indoleamine 2,3-dioxygenase activity in interferon-gamma primed mononuclear phagocytes.
Thomas SR; Mohr D; Stocker R
J Biol Chem; 1994 May; 269(20):14457-64. PubMed ID: 7514170
[TBL] [Abstract][Full Text] [Related]
17. Possible role of nitric oxide in the development of L-2-chloropropionic acid-induced cerebellar granule cell necrosis.
Widdowson PS; Gyte A; Simpson MG; Farnworth M; Dunn D; Moore RB; Wyatt I; Lock EA
Br J Pharmacol; 1996 Apr; 117(8):1761-7. PubMed ID: 8732288
[TBL] [Abstract][Full Text] [Related]
18. The modulation of IL-6 and TNF-alpha release by nitric oxide following stimulation of J774 cells with LPS and IFN-gamma.
Deakin AM; Payne AN; Whittle BJ; Moncada S
Cytokine; 1995 Jul; 7(5):408-16. PubMed ID: 7578978
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of substrate-analogue inhibitors on nitric oxide synthase dimerization.
Lee KS; Lee DK; Jeoung D; Lee H; Choe J; Ha KS; Won MH; Kwon YG; Kim YM
Biochem Biophys Res Commun; 2012 Feb; 418(1):49-55. PubMed ID: 22240022
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of L-N5-(1-iminoethyl)-ornithine on tone and endothelium-dependent vasodilator responses.
DeWitt BJ; Champion HC; Marrone JR; McNamara DB; Giles TD; Greenberg SS; Kadowitz PJ
Am J Physiol; 1997 Sep; 273(3 Pt 1):L588-94. PubMed ID: 9316493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
